Reversing pupil dilation in children after eye exams
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial tests eye drops that may help children's pupils return to normal faster after a routine eye exam. It compares three different drops to see which works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 12 years old.
- Your child must be having a routine eye exam that uses dilating drops.
- You and your child must agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether atropine eye drops can reduce the progression of myopia (nearsightedness, where you have trouble seeing far away) in children. It might help slow down the worsening of vision over time.
This trial tests whether atropine eye drops can slow down nearsightedness (myopia) that often happens after cataract surgery in young children. If your child is eligible, they will receive the drops to help keep their vision from getting worse.
This study tests eye drops to improve how a child’s eyes line up and how well they can use both eyes together. It may help children with certain types of outward eye drifting (intermittent exotropia/exophoria).
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This study looks at how different pain treatments affect a child’s pupils (the dark center of the eye). It may help doctors better understand which pain medicines are working and how to measure pain treatment effects more accurately.
This study tests a new eye drop medicine (T10430) to see if it can slow down how fast children's nearsightedness gets worse. The trial will measure whether the drops are safe and effective for kids ages 6–11.
Hear when a new Pupillary Constriction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.